Cargando…
Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety
Background: Autistic Spectrum Disorder (ASD) is a common neurodevelopmental disorder and no effective treatment for the core symptoms is currently available. The present study is part of a larger clinical trial assessing the effects of cannabis oil on autism co-morbidities. Objectives: The aim of th...
Autores principales: | Stolar, Orit, Hazan, Ariela, Vissoker, Roni Enten, Kishk, Ibrahim Abu, Barchel, Dana, Lezinger, Mirit, Dagan, Adi, Treves, Nir, Meiri, David, Berkovitch, Matitiahu, Kohn, Elkana, Heyman, Eli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559854/ https://www.ncbi.nlm.nih.gov/pubmed/36249785 http://dx.doi.org/10.3389/fphar.2022.977484 |
Ejemplares similares
-
Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
por: Hacohen, Micha, et al.
Publicado: (2022) -
Therapeutic drug monitoring of lacosamide among children: is it helpful?
por: Kohn, Elkana, et al.
Publicado: (2023) -
The Relations between Repetitive Behaviors and Family Accommodation among Children with Autism: A Mixed-Methods Study
por: Shiloh, Gal, et al.
Publicado: (2023) -
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
por: Treves, Nir, et al.
Publicado: (2021) -
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
por: Barchel, Dana, et al.
Publicado: (2019)